|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 376.2 SEK | +0.87% |
|
+19.59% | +13.96% |
| Apr. 24 | Nordic Shares Declined Wednesday; Svenska Handelsbnkn Ser A Fell Furthest | DJ |
| Apr. 24 | Transcript : Xvivo Perfusion AB, Q1 2024 Earnings Call, Apr 24, 2024 |
Xvivo Perfusion AB (publ) reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was SEK 140.62 million compared to SEK 92.65 million a year ago. Net income was SEK 14.18 million compared to SEK 4.77 million a year ago.
Basic earnings per share from continuing operations was SEK 0.48 compared to SEK 0.16 a year ago. Diluted earnings per share from continuing operations was SEK 0.48 compared to SEK 0.16 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +13.96% | 1.07B | |
| -2.20% | 187B | |
| -1.74% | 106B | |
| -3.98% | 66.9B | |
| +0.16% | 49.45B | |
| +16.25% | 48B | |
| +4.06% | 40.84B | |
| +3.44% | 26.48B | |
| +1.09% | 26.25B | |
| +12.96% | 24.62B |
XVIVO PERFUSION AB 
